default search action

combined dblp search
author search
venue search
publication search

ask others

George Daniel Radavoi

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

2020 – today

see FAQ

What is the meaning of the colors in the publication lists?

2024
[j2]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/jimaging/BolocanSSMMRCRDJ24
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jimaging/BolocanSSMMRCRDJ24
Vlad-Octavian Bolocan, Mihaela Secareanu, Elena Sava, Cosmin Medar, Loredana Sabina Cornelia Manolescu, Alexandru-Stefan Catalin Rascu, Maria Glencora Costache, George Daniel Radavoi, Robert-Andrei Dobran, Viorel Jinga:
Correction: Bolocan et al. Convolutional Neural Network Model for Segmentation and Classification of Clear Cell Renal Cell Carcinoma Based on Multiphase CT Images. J. Imaging 2023, 9, 280. J. Imaging 10(2): 35 (2024)
2023
[j1]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/jimaging/BolocanSSMMRCRDJ23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jimaging/BolocanSSMMRCRDJ23
Vlad-Octavian Bolocan, Mihaela Secareanu, Elena Sava, Cosmin Medar, Loredana Sabina Cornelia Manolescu, Alexandru-Stefan Catalin Rascu, Maria Glencora Costache, George Daniel Radavoi, Robert-Andrei Dobran, Viorel Jinga:
Convolutional Neural Network Model for Segmentation and Classification of Clear Cell Renal Cell Carcinoma Based on Multiphase CT Images. J. Imaging 9(12): 280 (2023)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.